Searchable abstracts of presentations at key conferences in endocrinology

ea0016p51 | Adrenal | ECE2008

Adrenocortical changes and arterial hypertension in lipoatrophic A-ZIP/F-1 mice

Lamounier-Zepter Valeria , Bornstein Stefan , Kunes Jaroslav , Zicha Jozef , Krsek Michal , Ehrhart-Bornstein Monika , Ziegler Christian , Kiessling Andrea , Funk Richard , Haluzik Martin

The A-ZIP/F-1 transgenic mouse is a model of lipoatrophic diabetes with severe insulin resistance, hyperglycemia and hyperlipidemia. Recently, a regulatory role of adipose tissue on adrenal gland function and blood pressure has been suggested. To further explore the importance of adipose tissue in the regulation of adrenal function and blood pressure, we studied this mouse model of lipodystrophy. A-ZIP/F-1 mice exhibit significantly elevated systolic and diastolic blood pressu...

ea0016p283 | Endocrine tumours | ECE2008

Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism in MEN-1 patients

Faggiano Antongiulio , Tavares Lidice , Milone Francesco , Mansueto Gelsomina , Ramundo Valeria , De Caro Maria Laura Del Basso , Lombardi Gaetano , De Rosa Gaetano , Colao Annamaria

Background: Expression of somatostatin receptor (SST) and therapy with somatostatin analogues have been scarcely investigated in parathyroid tumors.Objective: To evaluate the effects of depot long acting octreotide (OCT-LAR) on primary hyperparathyroidism in patients affected with multiple endocrine neoplasia type 1 (MEN-1).Subjects and methods: Eight patients with a genetically confirmed MEN-1 were enrolled. All patients presented...

ea0014oc1.2 | Thyroid clinical | ECE2007

Expression gene profile may be useful for the diagnosis of thyroid malignancies

Piampiani Pamela , Romei Cristina , Cosci Barbara , Vivaldi Agnese , Ciampi Raffaele , Viola David , Bottici Valeria , Giannini Riccardo , Basolo Fulvio , Pinchera Aldo , Elisei Rossella

Although 20% of follicular neoplasms are papillary thyroid carcinoma (PTC), their cytological diagnosis is not diagnostic. A different profile of gene expression between malignant and benign thyroid tumors has been reported. Aim of this study was to identify a gene expression profile to be used in distinguishing malignant from benign thyroid neoplasms. By real-time RT-PCR we analyzed mRNA expression of 6 thyroid differentiation genes (TTF-1, PAX8, TPO, TSHr, NIS and Tg) and 5 ...

ea0056oc13.4 | The curious case of growth hormone | ECE2018

Effects of pegvisomant on glucose metabolism in acromegaly: A meta-analysis of prospective interventional studies

Feola Tiziana , Cozzolino Alessia , Puliani Giulia , Sbardella Emilia , Gianfrilli Daniele , Hasenmajer Valeria , Simonelli Ilaria , Pasqualetti Patrizio , Lenzi Andrea , Isidori Andrea M.

Introduction: Glucose metabolism impairment is a common complication of acromegaly. Pegvisomant (PEG) is used as second-line medical treatment in acromegaly. Data from literature suggest a positive effect of PEG on glucose metabolism but a meta-analysis has never been performed.Aim: To address the following questions: i) does PEG affect glucose metabolism? ii) does the effect correlate with disease control?Methods: We performed a m...

ea0073oc5.5 | Oral Communications 5: Thyroid | ECE2021

Role of miR-139–5p in radioiodine-refractory thyroid cancers

Pecce Valeria , Abballe Luana , Sponziello Marialuisa , Brunelli Chiara , Verrienti Antonella , Annunziata Salvatore , Grani Giorgio , Fadda Guido , Salvatori Massimo , Russo Diego , Durante Cosimo

Radioiodide 131I (RAI) is the therapy of choice for radioiodine-avid differentiated thyroid cancer (DTC). However, 5–15% of DTC patients become RAI refractory (RAIR), and the 10-year survival rate for metastatic disease decreases to 10%. The failure of RAI response is mainly due to the loss of thyroid differentiation, that leads to the loss of expression/function of components of iodide metabolism, first of all the Na/I symporter (NIS). The finding that the MAPK pathway i...

ea0073oc12.3 | Oral Communications 12: Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective effect in diabetic rats with experimental myocardial infarction

Simanenkova Anna , Minasian Sarkis , Karonova Tatiana , Vlasov Timur , Timkina Natalya , Khalzova Aleksandra , Shpilevaya Oksana , Shimshilashvili Anzhelika , Timofeeva Valeria , Borshchev Yury , Galagudza Mikhail

Background:Myocardial infarction (MI) is one of the leading causes of mortality in patients with type 2 diabetes mellitus (DM), therefore it is essential to give preference to a glucose-lowering drug having most prominent cardioprotective properties. Sodium-glucose co-transporter-2 inhibitors (SGLT-2i) have demonstrated an ability to decrease heart failure manifestations, cardiovascular death frequency not having a certain influence on MI occurrence. On ...

ea0073yi2 | Young Investigator Awards | ECE2021

Efficacy of the Anti-BAFF monoclonal antibody belimumab vs methylprednisolone in active moderate-severe graves’ orbitopathy: Preliminary analysis of a randomized controlled trial

Vittoria Favero , Currò Nicola , Campi Irene , Lazzaroni Elisa , Covelli Danila , Vannucchi Guia , Dazzi Davide , Muller Ilaria , Minorini Valeria , Guastella Claudio , Maura Arosio , Salvi Mario

BackgroundSerum B cell stimulating factor (BAFF) has been shown to be elevated in Graves’ disease (Vannucchi 2012). In addition, BAFF and its receptor have been shown to be expressed on lymphocytes infiltrating the thyroid in Graves’ disease and also on thyrocytes (Campi 2015).AimsWe tested in a single-blind randomized controlled trial (EudraCT 2015–002127–26) whether the administration ...

ea0073pep13.1 | Presented ePosters 13: Pituitary and Neuroendocrinology | ECE2021

Factors associated with Aryl hydrocarbon Interacting Protein (AIP) expression in gonadotroph pituitary neuroendocrine tumours (Pit-NETs)

Polidoro Michela A. , Feola Tiziana , Gianno Francesca , Palumbo Valeria , Arcella Antonietta , Morace Roberta , De Angelis Michelangelo , Giangaspero Felice , Esposito Vincenzo , Jaffrain-Rea Marie-Lise

IntroductionAIP is a predisposing gene for GH/PRL-secreting PitNETs. Clinically non-functioning PitNETs (NFPT) occasionally occur in the setting of AIP germline mutations, sometimes arising from Pit-1 lineages. However, AIP overexpression has been observed in unselected NFPT and associations with the gonadotroph phenotype and/or tumour aggressiveness were suggested. We wished to evaluate the significance of AIP expression in gonadotroph tumours defined b...

ea0073aep29 | Adrenal and Cardiovascular Endocrinology | ECE2021

Incidental detection of adrenal hyperplasia and mortality in patients with suspected SARS-CoV-2 Infection

Reimondo Giuseppe , Solitro Federica , Puglisi Soraya , Casale Davide , Tiranti Giorgia Maria , Perini Anna , Cultrera Alessandra , Caramello Valeria , Boccuzzi Adriana , Pia Anna , Terzolo Massimo , Veltri Andrea

Many patients affected by SARS-CoV-2 disease (COVID) have associated comorbidities (arterial hypertension, obesity, diabetes mellitus, thrombophilia) that are also tied to autonomous cortisol secretion. However, the prevalence of diseases of the adrenal glands in COVID patients is presently unknown. Since the visualization of the adrenal glands is almost always available in chest CT performed in patients with suspected or confirmed SARS-CoV-2 infection, the evaluation of adren...

ea0075p11 | Pituitary and neuroendocrinology | EYES2021

Pituitary adenoma consistency is associated with postoperative hormonal deficits: a retrospective study on 50 patients undergoing transsphenoidal adenomectomy

De Alcubierre Dario , Pofi Riccardo , Sbardella Emilia , Puliani Giulia , Hasenmajer Valeria , Sada Valentina , Zaccagnino Antonella , Ruggeri Andrea G. , Gianfrilli Daniele , Isidori Andrea M.

Background: Little is known about possible predictors for hormonal function following pituitary surgery. Tumor consistency has recently emerged as a key factor in surgical planning for pituitary adenomas, influencing both the surgical outcome and the onset of postoperative complications. However, its impact on postoperative endocrine function has yet to be explored.Objectives: To evaluate the impact of tumor consistency on the development of postoperativ...